Precautionary recall of seven lots of Jext pens

News Category: -none-

Date: 30/06/2014

Users advised to exchange affected pens at their pharmacy or clinic

The Irish Medicines Board (IMB) today advised that, as a precautionary measure, the manufacturer, ALK-Abello, is recalling certain lots of the Jext range of treatments for acute allergic reactions. The recall concerns certain lots of Jext 150mcg (Junior) solution for injection and Jext 300mcg solution for injection which come in pre-filled pens. Seven lots of the pens are impacted by a quality defect which potentially leads to injection failure. The defect is estimated to affect, on average, 0.04% of pens - 1 in every 2,500 - per lot. 

Advice to Patients and Carers: 

  • If you are in possession of a Jext pen from an affected lot below, please return it to a pharmacy, where a replacement, unaffected pen will be provided free-of-charge.
  • If you are in possession of a Jext pen with a lot number not listed, then the pen is unaffected and you do not need to take any action.
  • Patients are also reminded that, in line with current medical guidelines, it is advised that they continue to carry two pens at all times.
The lot number is displayed on the pen or the outer box and usually preceded by the letters ‘LOT’.

Affected Lots:
  • Jext 150mcg 
            Lot 0000884201     Expiry 31/03/2015 
            Lot 0000871645     Expiry 28/02/2015 
            Lot 0000785382     Expiry 31/01/2015 

  • Jext 300mcg 
            Lot 0000874584     Expiry 28/02/2015 
            Lot 0000816025     Expiry 31/01/2015 
            Lot 0000774776     Expiry 31/01/2015 
            Lot 0000780783     Expiry 31/01/2015 

Media Queries
  • Orla Molloy / Siobhan Molloy 087 770 5108/ 086 817 5066
  • Weber Shandwick PR (01) 679 8600

« Back